Maa: Yhdysvallat
Kieli: englanti
Lähde: NLM (National Library of Medicine)
Omeprazole (UNII: KG60484QX9) (Omeprazole - UNII:KG60484QX9)
KAISER FOUNDATION HOSPITALS
Omeprazole
Omeprazole 40 mg
PRESCRIPTION DRUG
Abbreviated New Drug Application
OMEPRAZOLE - OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS KAISER FOUNDATION HOSPITALS ---------- FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 DUODENAL ULCER (ADULTS) Omeprazole delayed-release capsules USP are indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy. Omeprazole delayed-release capsules USP in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with _H. pylori_ infection and duodenal ulcer disease (active or up to 1- year history) to eradicate _H. pylori_ in adults. Omeprazole delayed-release capsules USP in combination with clarithromycin is indicated for treatment of patients with _H. pylori_ infection and duodenal ulcer disease to eradicate _H. pylori_ in adults. Eradication of _H. pylori_ has been shown to reduce the risk of duodenal ulcer recurrence [_see Clinical_ _Studies (14.1) and Dosage and Administration (2)_]. Among patients who fail therapy, Omeprazole delayed-release capsules USP with clarithromycin is more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted. [_See Microbiology section (12.4)_], and the clarithromycin package insert, Microbiology section.) 1.2 GASTRIC ULCER (ADULTS) Omeprazole delayed-release capsules USP are indicated for short-term treatment (4 to 8 weeks) of active benign gastric ulcer in adults. [_See Clinical Studies (14.2)_] 1.3 TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) (ADULTS AND PEDIATRIC PATIENTS) _Symptomatic GERD_ Omeprazole delayed-release capsules USP are indicated for the treatment of heartburn and other symptoms associated with GERD in pediatric patients and adults. _Erosive Esophagitis_ Omeprazole delayed-release caps Lue koko asiakirja